MENU
+Compare
PCVX
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$85.75
Change
-$4.11 (-4.57%)
Capitalization
10.69B

PCVX Vaxcyte Forecast, Technical & Fundamental Analysis

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PCVX with price predictions
Dec 17, 2024

PCVX's RSI Indicator climbs out of oversold territory

The RSI Indicator for PCVX moved out of oversold territory on November 25, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PCVX just turned positive on November 27, 2024. Looking at past instances where PCVX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

PCVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PCVX as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PCVX entered a downward trend on November 22, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PCVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.277) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). PCVX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PCVX is expected to report earnings to rise 34.94% to -112 cents per share on March 03

Vaxcyte PCVX Stock Earnings Reports
Q4'24
Est.
$-1.12
Q3'24
Beat
by $0.27
Q2'24
Missed
by $0.12
Q1'24
Beat
by $0.28
Q4'23
Missed
by $0.77
The last earnings report on November 05 showed earnings per share of -82 cents, beating the estimate of -110 cents. With 1.25M shares outstanding, the current market capitalization sits at 10.69B.
A.I. Advisor
published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
825 Industrial Road
Phone
+1 650 837-0111
Employees
254
Web
https://www.vaxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VXUS61.27-0.22
-0.36%
Vanguard Total International Stock ETF
PSCE48.49-0.37
-0.76%
Invesco S&P SmallCap Energy ETF
USXF50.95-0.54
-1.05%
iShares® ESG Advanced MSCI USA ETF
VFMF134.97-1.52
-1.11%
Vanguard US Multifactor ETF
DVLU29.89-0.54
-1.77%
First Trust Dorsey Wright Momt & Val ETF

PCVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.41%
ORKA - PCVX
61%
Loosely correlated
-0.49%
LOGC - PCVX
45%
Loosely correlated
-3.62%
RXRX - PCVX
42%
Loosely correlated
-4.30%
DYN - PCVX
41%
Loosely correlated
+0.23%
EXAI - PCVX
36%
Loosely correlated
N/A
More